Health & Wellbeing: Psychedelics and pharmaceuticals: The next revolution in healthcare

With the unpredictability of Covid and the loneliness of lockdowns, we’ve seen a 30% spike in mental health issues. Psychedelics have always been a huge talking point, but now they’re being seen in a whole new light as a potential solution. Could we see psychedelics legalised to treat a host of mental health issues? Our panel of experts look at what this revolutionary shift could mean for the future of healthcare and pharmaceutical companies.

Featuring:
Lars Wilde - Co-Founder, President, CBO - COMPASS Pathways
David Erritzoe - Clinical Senior Lecturer and Consultant Psychiatrist - Imperial College London
Katherine Templar Lewis - Creative Scientist - Kinda Studios

CogX Festival: Register Your Interest Today
[ Ссылка ]
#CogX2021 #JoinTheConversation

свернуть